Eglumetad monohydrate
Product Specifications
CAS Number
209216-09-1
Bioactivity
Eglumetad (also known as LY354740) is an investigational compound developed by Eli Lilly and Company, currently under research for the treatment of anxiety disorders and substance addiction. This compound originates from glutamate, demonstrating a novel mechanism of action.
Smiles
C(O)(=O)[C@@]1(N)[C@@]2([C@@H](C(O)=O)[C@@]2(CC1)[H])[H].O
Molecular Formula
C8H13NO5
Molecular Weight
203.19
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
7-05060 10 µg
Recombinant Human Eukaryotic Translation Initiation Factor 4E
Sign In for Pricing
View Details 
abx495060-01 96 Tests
Human Calmodulin Regulated Spectrin Associated Protein 1 (CAMSAP1) CLIA Kit
Sign In for Pricing
View Details abx495060-02 5x 96 Tests
Human Calmodulin Regulated Spectrin Associated Protein 1 (CAMSAP1) CLIA Kit
Sign In for Pricing
View Details